Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cancer Research|January 27, 2011
Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytesAsís Palazón, Alvaro Teijeira, Iván Martínez-Forero, et al.
Cancer Research|August 24, 2016
Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and CrossprimingMaría E Rodriguez-Ruiz, Inmaculada Rodriguez, Saray Garasa, et al.
Cancer Research|June 27, 2015
Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient MiceMiguel F Sanmamed, Inmaculada Rodriguez, Kurt A Schalper, et al.
Cancer Research|August 6, 2009
Discovery of BMS-641988, a novel and potent inhibitor of androgen receptor signaling for the treatment of prostate cancerRicardo M Attar, Maria Jure-Kunkel, Aaron Balog, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2008
Identification and optimization of a novel series of [2.2.1]-oxabicyclo imide-based androgen receptor antagonistsMark E Salvati, Aaron Balog, Weifang Shan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal AntibodyNeil H Segal, Theodore F Logan, F Stephen Hodi, et al.
Clinical and Translational Science|May 23, 2026
Safety and Efficacy of HexaBody-DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed HepatotoxicityMarije B Overdijk, Kristin Strumane, Ruth Plummer, et al.
Cancer Research|February 3, 2021
Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody-Drug Conjugate and Immune Checkpoint BlockadeJulia Boshuizen, Nora Pencheva, Oscar Krijgsman, et al.
Oncoimmunology|February 21, 2022
An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulationAlexander Muik, Isil Altintas, Friederike Gieseke, et al.
Journal for Immunotherapy of Cancer|June 10, 2022
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activityAlexander Muik, Homer C Adams 3rd, Friederike Gieseke, et al.
Pageof 4